| Year | Title | Author(s) |
| 2018 |
EPO does not promote interaction between the erythropoietin and beta-common receptors |
Shing, KSCT Broughton, SE Nero, TL Gillinder, K Ilsley, MD Ramshaw, H Lopez, AF Griffin, MDW Parker, MW Perkins, AC Dhagat, U |
| 2018 |
Tolerance to sustained activation of the cAMP/Creb pathway activity in osteoblastic cells is enabled by loss of p53 |
Walia, MK Taylor, S Ho, PWM Martin, TJ Walkley, CR |
| 2018 |
Diabetes associated with immune checkpoint inhibition: presentation and management challenges |
Galligan, A Xu, W Fourlanos, S Nankervis, A Chiang, C Mant, AM Parente, P Rischin, D Krishnamurthy, B Sandhu, S Colman, PG |
| 2018 |
Defining Outcomes for -cell Replacement Therapy in the Treatment of Diabetes: A Consensus Report on the Igls Criteria From the IPITA/EPITA Opinion Leaders Workshop |
Rickels, MR Stock, PG de Koning, EJP Piemonti, L Pratschke, J Alejandro, R Bellin, MD Berney, T Choudhary, P Johnson, PR Kandaswamy, R Kay, TWH Keymeulen, B Kudva, YC Latres, E Langer, RM Lehmann, R Ludwig, B Markmann, JF Marinac, M Odorico, JS Pattou, F Senior, PA Shaw, JAM Vantyghem, MC White, S |
| 2018 |
Metformin inhibits gluconeogenesis via a redox-dependent mechanism in vivo |
Madiraju, AK Qiu, Y Perry, RJ Rahimi, Y Zhang, XM Zhang, DY Camporez, JPG Cline, GW Butrico, GM Kemp, BE Casals, G Steinberg, GR Vatner, DF Petersen, KF Shulman, GI |
| 2018 |
Protagonist or antagonist? The complex roles of retinoids in the regulation of hematopoietic stem cells and their specification from pluripotent stem cells |
Grace, CS Mikkola, HKA Dou, DR Calvanese, V Ronn, RE Purton, LE |
| 2018 |
Small animal models for the study of bone sarcoma pathogenesis: characteristics, therapeutic interests and limitations |
Jacques, C Renema, N Lezot, F Ory, B Walkley, CR Grigoriadis, AE Heymann, D |
| 2018 |
Phosphorylation of Acetyl-CoA Carboxylase by AMPK Reduces Renal Fibrosis and Is Essential for the Anti-Fibrotic Effect of Metformin |
Lee, M Katerelos, M Gleich, K Galic, S Kemp, BE Mount, PF Power, DA |
| 2018 |
Y1 receptor deficiency in beta-cells leads to increased adiposity and impaired glucose metabolism |
Loh, K Shi, YC Bensellam, M Lee, K Laybutt, DR Herzog, H |
| 2018 |
AMPK-ACC signaling modulates platelet phospholipids and potentiates thrombus formation |
Lepropre, S Kautbally, S Octave, M Ginion, A Onselaer, MB Steinberg, GR Kemp, BE Hego, A Wera, O Brouns, S Swieringa, F Giera, M Darley-Usmar, VM Ambroise, J Guigas, B Heemskerk, J Bertrand, L Oury, C Beauloye, C Horman, S |
| 2018 |
Neprilysin Inhibitors and Bradykinin |
Campbell, DJ |
| 2018 |
mTORC1 plays an important role in osteoblastic regulation of B-lymphopoiesis |
Martin, SK Fitter, S El Khawanky, N Grose, RH Walkley, CR Purton, LE Ruegg, MA Hall, MN Gronthos, S Zannettino, ACW |
| 2018 |
Detection of clinically relevant early genomic lesions in B-cell malignancies from circulating tumour DNA using a single hybridisation-based next generation sequencing assay |
Blombery, PA Ryland, GL Markham, J Guinto, J Wall, M McBean, M Jones, K Thompson, ER Cameron, DL Papenfuss, AT Prince, MH Dickinson, M Westerman, DA |
| 2018 |
Expression of miR-206 in human islets and its role in glucokinase regulation |
Joglekar, MV Wong, WKM Maynard, CL Umrani, MR Martin, D Loudovaris, T Thomas, HE Dalgaard, LT Hardikar, AA |
| 2018 |
Type I Interferon Signaling Is Required for Dacryoadenitis in the Nonobese Diabetic Mouse Model of Sjogren Syndrome |
Chaly, Y Barr, JY Sullivan, DA Thomas, HE Brodnicki, TC Lieberman, SM |
Page 5 of 6 pages ‹ First < 3 4 5 6 >